Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human alpha-Mannosidase

EU orphan designation number: EU/3/04/260   
Active ingredient: Recombinant human alpha-Mannosidase
Indication: Treatment of alpha-Mannosidosis
Sponsor: Zymenex A/S
Roskildevej 12C, DK-3400 Hillerød, Danmark

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
28/01/2005 Centralised Orphan - Designation EMEA/OD/074/04 (2005)242 of 26/01/2005
04/02/2005 Other procedure